ES2042153T3 - Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion. - Google Patents

Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion.

Info

Publication number
ES2042153T3
ES2042153T3 ES199090114108T ES90114108T ES2042153T3 ES 2042153 T3 ES2042153 T3 ES 2042153T3 ES 199090114108 T ES199090114108 T ES 199090114108T ES 90114108 T ES90114108 T ES 90114108T ES 2042153 T3 ES2042153 T3 ES 2042153T3
Authority
ES
Spain
Prior art keywords
weight
parts
agents
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199090114108T
Other languages
English (en)
Inventor
Manfred Lohner
Klaus Dr. Posselt
Ute Dr. Med. Vogtle-Junkert
Hans H. Prof. Dr. Med. Wagener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dolorgiet GmbH and Co KG
Original Assignee
Dolorgiet GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolorgiet GmbH and Co KG filed Critical Dolorgiet GmbH and Co KG
Application granted granted Critical
Publication of ES2042153T3 publication Critical patent/ES2042153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Instructional Devices (AREA)
  • Endoscopes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO SE REFIERE A UN MEDIO QUE SE UTILIZA PARA EL TRATAMIENTO DE ESTADOS DE DOLOR AGUDO COMO DOLORES POSOPERATIVOS Y DOLORES TUMULARES Y CONSISTE EN CAPSULAS DE GELATINA BLANDAS QUE CONTIENEN DE 30 A 50 PARTES EN PESO DE IBUPROFEN Y DE 1,5 A 4 PARTES EN PESO DE CODEINA Y SUS SALES TOLERABLES FISIOLOGICAMENTE QUE PARCIALMENTE SE DILUYEN Y SE SUSPENDEN EN 68,5 A 48 PARTES EN PESO DE POLIOXIETILENO UNA MEZCLA DE 30 A 76 PARTES EN PESO DE POLIOXIETILENO XIPROPILENO A 40 PARTES EN PESO DE UNOS TENSIOACTIVOS TOLERABLES FISIOLOGICAMENTE.
ES199090114108T 1989-08-17 1990-07-24 Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion. Expired - Lifetime ES2042153T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927113A DE3927113C2 (de) 1989-08-17 1989-08-17 Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2042153T3 true ES2042153T3 (es) 1993-12-01

Family

ID=6387265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199090114108T Expired - Lifetime ES2042153T3 (es) 1989-08-17 1990-07-24 Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion.

Country Status (12)

Country Link
US (1) US5173304A (es)
EP (1) EP0413171B1 (es)
JP (1) JPH03169809A (es)
AT (1) ATE89730T1 (es)
CA (1) CA2023349A1 (es)
DE (2) DE3927113C2 (es)
DK (1) DK0413171T3 (es)
ES (1) ES2042153T3 (es)
FI (1) FI904092A0 (es)
NO (1) NO903608L (es)
YU (1) YU149290A (es)
ZA (1) ZA906486B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
GB2260081B (en) * 1991-10-04 1995-11-29 Euro Celtique Sa Use of ibuprofen/codeine mixtures in treatment of chronic pain
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5468502A (en) * 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
JP2000507991A (ja) * 1997-10-07 2000-06-27 フイズ テクノロジーズ リミテッド 即時放出薬剤送達形態
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
DE60238276D1 (de) * 2001-12-13 2010-12-23 Vital Health Sciences Pty Ltd Transdermaler transport von verbindungen
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
ES2695401T3 (es) * 2003-02-12 2019-01-04 Syncera Inc Composiciones de aleación de polímeros de óxido de alquileno aleatorios y no aleatorios
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
NZ549567A (en) 2004-03-03 2009-10-30 Vital Health Sciences Pty Ltd Formulations comprising a tocopheryl phosphate tertiary amine alkaloid complex
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US20090233881A1 (en) * 2005-03-03 2009-09-17 Vital Health Sciences Pty. Ltd Compounds having anti-cancer properties
WO2006133506A1 (en) * 2005-06-17 2006-12-21 Vital Health Sciences Pty Ltd A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2631653A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
US20100030576A1 (en) * 2008-07-30 2010-02-04 Mclane Advanced Technologies, Llc System and Method for Pain Management
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
MX2012011355A (es) 2010-03-30 2012-11-30 Phosphagenics Ltd Parche de suministro transdermico.
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
NZ754168A (en) 2016-12-21 2024-08-30 Avecho Biotechnology Ltd Process for phosphorylating a complex alcohol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4894234A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for antiarrhythmics
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4923898A (en) * 1984-12-26 1990-05-08 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
ATE89730T1 (de) 1993-06-15
DE3927113C2 (de) 1993-11-25
JPH03169809A (ja) 1991-07-23
DK0413171T3 (da) 1993-10-04
DE59001544D1 (de) 1993-07-01
NO903608L (no) 1991-02-18
US5173304A (en) 1992-12-22
YU149290A (sh) 1992-12-21
FI904092A0 (fi) 1990-08-17
CA2023349A1 (en) 1991-02-18
NO903608D0 (no) 1990-08-16
DE3927113A1 (de) 1991-02-21
EP0413171A1 (de) 1991-02-20
ZA906486B (en) 1991-06-26
EP0413171B1 (de) 1993-05-26

Similar Documents

Publication Publication Date Title
ES2042153T3 (es) Agentes para el tratamiento de estados de dolor graves y procedimientopara su preparacion.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
ES2074124T5 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
DE19675039I2 (de) Bis-dimethoxymethyl(trimethox-ybenzyl)isochinolinium-Salze ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATA186692A (de) Pharmazeutische zusammensetzung
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
DK305087A (da) Buprenorphinholdigt farmaceutisk suppositorium
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
ES512748A0 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
SE8205849L (sv) Nya furobensazepiner, deras framstellning och anvendning
CA2066945A1 (en) Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
ES8103041A1 (es) Procedimiento para la preparacion de sulfonilsemicarbazidas
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413171

Country of ref document: ES